Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   HEPATITIS MONTHLY   APRIL 2011 , Volume 11 , Number 4 (33); Page(s) 240 To 246.
 
Paper: 

THE OPTIMAL DOSE OF RIBAVIRIN FOR CHRONIC HEPATITIS C: FROM LITERATURE EVIDENCE TO CLINICAL PRACTICE

 
 
Author(s):  ABENAVOLI LUDOVICO*, MAZZA MARTA, ALMASIO PIERO L.
 
* DEPARTMENT OF EXPERI¬MENTAL AND CLINICAL MEDICINE, UNIVERSITY MAGNA GRACIA, VIALE EUROPA, 88100, CATANZARO, ITALY
 
Abstract: 

Approximately 170 million people worldwide are chronically infected by hepatitis C virus (HCV), which can result in progressive hepatic injury and fibrosis, culminating in cirrhosis and end-stage liver disease. The benchmark therapy for untreated HCV patients is a combination of pegylated interferon-alpha (PEG-IFN) and ribavirin (RBV). Several studies have suggested several potential new approaches to improve HCV therapy-optimization of the dose and duration of RBV therapy, accompanied by careful clinical management, is crucial in ensuring the greatest likelihood of a long response to therapy. RBV causes serious side effects, but in clinical practice, there are no alternatives for the treatment of HCV infection. Based on our results, weight-based doses of RBV are advantageous for genotype 1-infected patients, but its success in genotype 2- and 3-infected patients is unknown, particularly for shorter treatment durations.

 
Keyword(s): HEPATITIS C VIRUS, RIBAVIRIN, DOSE-RESPONSE
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

ABENAVOLI, L., & MAZZA, M., & ALMASIO, P. (2011). THE OPTIMAL DOSE OF RIBAVIRIN FOR CHRONIC HEPATITIS C: FROM LITERATURE EVIDENCE TO CLINICAL PRACTICE. HEPATITIS MONTHLY, 11(4 (33)), 240-246. https://www.sid.ir/en/journal/ViewPaper.aspx?id=193737



Vancouver: Copy

ABENAVOLI LUDOVICO, MAZZA MARTA, ALMASIO PIERO L.. THE OPTIMAL DOSE OF RIBAVIRIN FOR CHRONIC HEPATITIS C: FROM LITERATURE EVIDENCE TO CLINICAL PRACTICE. HEPATITIS MONTHLY. 2011 [cited 2021June16];11(4 (33)):240-246. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=193737



IEEE: Copy

ABENAVOLI, L., MAZZA, M., ALMASIO, P., 2011. THE OPTIMAL DOSE OF RIBAVIRIN FOR CHRONIC HEPATITIS C: FROM LITERATURE EVIDENCE TO CLINICAL PRACTICE. HEPATITIS MONTHLY, [online] 11(4 (33)), pp.240-246. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=193737.



 
  pdf-File
Yearly Visit 63
 
 
Latest on Blog
Enter SID Blog